uncertainties regarding the future development of Pfizers oral GIPR antagonist candidate, other earlier obesity programs or any other product candidates, including whether or when Pfizers oral GIPR antagonist candidate, other earlier obesity programs or any such other product candidates will advance to future studies or phases of development
[2] A 2025 randomised phase 1 trial in adults with overweight or obesity found that tirzepatide reduced overall appetite, food cravings, tendency to overeat, perceived hunger and reactivity to foods in the environment, while not increasing cognitive restraint
These medications have gained attention for their role in improving blood sugar control and supporting weight loss
If you cant keep fluids down for 24 hours, seek immediate medical attention
As a peptide that stimulates the bodys natural production of growth hormone, sermorelin is often prescribed in anti-aging